- Home
- ADPT vs BWLP Comparison
ADPT vs BWLP Comparison
Compare ADPT & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- BWLP
- Stock Information
- Founded
- ADPT 2009
- BWLP 1935
- Country
- ADPT United States
- BWLP Singapore
- Employees
- ADPT N/A
- BWLP N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- BWLP Marine Transportation
- Sector
- ADPT Health Care
- BWLP Consumer Discretionary
- Exchange
- ADPT Nasdaq
- BWLP Nasdaq
- Market Cap
- ADPT 2.6B
- BWLP 2.4B
- IPO Year
- ADPT 2019
- BWLP N/A
- Fundamental
- Price
- ADPT $20.36
- BWLP $12.37
- Analyst Decision
- ADPT Strong Buy
- BWLP
- Analyst Count
- ADPT 10
- BWLP 0
- Target Price
- ADPT $16.60
- BWLP N/A
- AVG Volume (30 Days)
- ADPT 2.4M
- BWLP 320.8K
- Earning Date
- ADPT 11-05-2025
- BWLP 12-02-2025
- Dividend Yield
- ADPT N/A
- BWLP 10.85%
- EPS Growth
- ADPT N/A
- BWLP N/A
- EPS
- ADPT N/A
- BWLP 1.50
- Revenue
- ADPT $252,754,000.00
- BWLP $3,554,740,000.00
- Revenue This Year
- ADPT $36.43
- BWLP N/A
- Revenue Next Year
- ADPT $12.31
- BWLP $4.24
- P/E Ratio
- ADPT N/A
- BWLP $8.57
- Revenue Growth
- ADPT 42.57
- BWLP 1.27
- 52 Week Low
- ADPT $4.76
- BWLP $7.86
- 52 Week High
- ADPT $20.76
- BWLP $16.60
- Technical
- Relative Strength Index (RSI)
- ADPT 73.37
- BWLP 38.42
- Support Level
- ADPT $13.28
- BWLP $12.62
- Resistance Level
- ADPT $14.24
- BWLP $13.41
- Average True Range (ATR)
- ADPT 1.19
- BWLP 0.33
- MACD
- ADPT 0.57
- BWLP -0.07
- Stochastic Oscillator
- ADPT 95.19
- BWLP 12.23
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.